SCHEMBL16159264

SCHEMBL16159264

c1cc(-c2ccc3c4ccc(-c5cccc(-c6cnco6)n5)cc4n(-c4cccc5ccccc45)c3c2)nc(-c2cnco2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
ROCK2 O75116 2/20 0.41
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MAP4K4 O95819 1/20 0.34
ALDH1A1 P00352 2/20 0.34
POLB P06746 2/20 0.34
HPGD P15428 2/20 0.34
PDK2 Q15119 1/20 0.34
GAA P10253 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
USP2 O75604 1/20 0.34
BLM P54132 1/20 0.34
PIK3R2 O00459 1/20 0.33
ADORA2A P29274 1/20 0.32
TDP1 Q9NUW8 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16159854 0.87 CYP11B1 (0.48) CYP11B1CYP11B2ROCK2PTGS1PTGS2
SCHEMBL16159212 0.87 ROCK2 (0.43) CYP11B1CYP11B2ROCK2PTGS1PTGS2
SCHEMBL16159081 0.86 CYP11B1 (0.50) CYP11B1CYP11B2ROCK2PTGS1PTGS2
SCHEMBL16159241 0.85 ROCK2 (0.43) CYP11B1CYP11B2ROCK2MEN1KMT2A
SCHEMBL16159624 0.84 CYP11B1 (0.45) CYP11B1CYP11B2ROCK2PTGS1PTGS2
SCHEMBL16159497 0.80 ROCK2 (0.54) CYP11B1CYP11B2ROCK2MEN1KMT2A
SCHEMBL9973679 0.80 CYP19A1 (0.43) CYP11B1CYP11B2KMT2AALDH1A1HPGD
SCHEMBL16159242 0.79 PIM1 (0.36) PTGS1PTGS2MEN1KMT2AALDH1A1
SCHEMBL16159259 0.79 ROCK2 (0.37) CYP11B1CYP11B2ROCK2MEN1KMT2A
SCHEMBL16159573 0.77 PTGS1 (0.35) PTGS1PTGS2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC CORPORATION (JP) 2016-04-28 US disclosed
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC CORPORATION (JP) 2016-04-28 US disclosed
WO-2014163173-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC株式会社 (JP) 2014-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME HVCN1, VDAC1, SLC26A3 CYP11B1 312/4885CYP11B2 420/4885ROCK2 3962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.